PRECiSE 2 Maintenance Phase: Efficacy in Patients with Fistulizing Crohns Disease

1
PRECiSE 2 Maintenance Phase Efficacy in Patients
with Fistulizing Crohns Disease
Certolizumab 400 mg s.c. injections q4 weeks
until week 24 Placebo until week 24 Final
assessment at week 26.
Adapted from Schreiber et al. 2008 Advances in
IBD, abstract O-0003.
2
(No Transcript)